Global Health Limited has announced the grant of 10,000 Employee Stock Options (ESOPs) to one employee under its GHL-Employee Long Term Share Based Incentive Plan 2024. The company's Nomination and Remuneration Committee approved this grant during its meeting held on March 24, 2026.

ESOP Grant Details

The stock options were granted under Part-A of the GHL LTIP 2024 Plan, specifically the GHL Employees Stock Option Scheme, 2024. The grant represents a strategic initiative to reward employee performance and foster long-term commitment to the organization.

Plan Objectives and Structure

The GHL LTIP 2024 Plan serves multiple strategic purposes for Global Health Limited. The scheme aims to:

• Reward employees for their association, dedication and contribution to company goals
• Attract, retain and motivate key talent through performance-based incentives
• Enable employees to become co-owners and create wealth through future ownership
• Contribute to overall corporate growth and profitability

The plan operates in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, ensuring adherence to regulatory requirements.

Vesting and Exercise Terms

The granted options follow a structured vesting and exercise framework designed to align employee interests with long-term company performance.

The options will vest according to the vesting schedule and conditions outlined in individual grant letters. Once vested, employees can exercise their options within the specified timeframe to convert them into equity shares.

Corporate Governance

The Nomination and Remuneration Committee meeting commenced at 1:45 PM and concluded at 2:00 PM on March 24, 2026. Company Secretary and Compliance Officer Rahul Ranjan communicated the decision to stock exchanges as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This ESOP grant reflects Global Health Limited's commitment to employee engagement and long-term value creation through equity participation. The plan positions the company to leverage employee ownership as a tool for sustained growth and performance enhancement.

Global Health Limited has announced its participation in scheduled analyst and institutional investor meetings organized by ICICI Securities Limited for March 2026. The company issued the regulatory intimation on March 18, 2026, in compliance with SEBI listing obligations under reference number GHL/2025-26/EXCH/112.

Meeting Schedule and Details

The healthcare company has confirmed its management's participation in group meetings with investors and analysts during the last week of March 2026. The meetings are being organized by ICICI Securities Limited and will be conducted in-person at two different locations.

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance in the official announcement. Global Health Limited specifically stated that no unpublished price sensitive information is proposed to be shared during these investor interactions. This disclosure aligns with SEBI regulations governing information sharing in investor meetings.

The meetings are being conducted pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The regulatory filing was addressed to both BSE Limited and National Stock Exchange of India Limited, with Company Secretary and Compliance Officer Rahul Ranjan signing the document on March 18, 2026.

Meeting Flexibility and Contingencies

Global Health Limited has included a provision for potential schedule modifications in its announcement. The company noted that the meeting schedule remains subject to change in case of unforeseen circumstances on the part of analysts, investors, or the company itself. This flexibility clause provides accommodation for any last-minute adjustments that may be required by participating parties.

The formal communication was sent to the General Manager of BSE Limited's Department of Corporate Services and the Manager of NSE's Listing Department, ensuring proper regulatory notification across both major Indian stock exchanges.